From: Completion thyroidectomy: predicting bilateral disease
Pasieka et al. 1992 [10] N = 60 | Kawaura et al. 2001 [11] N = 128 | Pacini et al. 2001 [12] N = 182 | Alzahrani et al. 2002 [13] N = 101 | Kim et al. 2004 [14] N = 81 | Grigsby et al. 2006 [15] N = 150 | Pitt et al. 2009 [16] N = 228b | |
---|---|---|---|---|---|---|---|
Malignancy on completion | 53 % | 56.3 % | 44 % | 51.5 % | 36 % | 41 % | 29 % |
Multifocality | 88 % (n = 14/16) | 76.6 % (n = 36/47) | NC | 53.5 % (n = 15/28) | 69 % (n = 20/29) | ---- | 45 % (n = 9/20) |
p < 0.001 | p > 0.05 | p = 0.045 | p < 0.001 | p = 0.02 | |||
Size of Tumor | NC | NC | NC | NC | NC | NC | NC |
Lymph node involvement | NC | 76.5 % (n = 13/17) | 73.3.% (n = 11/15) | ---- | NC | NC | NC |
p > 0.05 | p = 0.03 | ||||||
Age | ---- | NC | NC | a60.9 % (n = 14/23) | NC | NC | ---- |
p = 0.01 | |||||||
Gender | ---- | NC | NC | NC | ---- | NC | ---- |
Thyroiditis | ---- | NC | ---- | ---- | ---- | ---- | ---- |
Exposure to ionizing radiation | ---- | 100 % (n = 6/6) | ---- | ---- | ---- | ---- | ---- |
p > 0.05 | |||||||
Low vs High Risk | ---- | ---- | NC | ---- | ---- | NC | ---- |
Histopathologic Diagnosis | NC | ---- | NC | ---- | NC | ---- | ---- |
Coexistent Benign Nodule | ---- | ---- | ---- | ---- | NC | ---- | NC |
Extrathyroidal Extension | ---- | NC | ---- | a61.5 % (n = 16/26) | NC | ---- | NC |
p = 0.01 | |||||||
Serum Tg > 20 ng/ml | ---- | ---- | ---- | 56.7 % (n = 17/30) | ---- | ---- | ---- |
p = 0.026 | |||||||
PC variant | ---- | NC (Tall cell) | ---- | ---- | ---- | NC (Follicular) | NC (Follicular) |
Soft tissue invasion | ---- | ---- | ---- | ---- | NC | ---- | |
Vascular invasion | ---- | ---- | ---- | ---- | NC | NC | |
Resection margins | ---- | ---- | ---- | ---- | NC | NC | |
Tumor capsular invasion | ---- | ---- | ---- | ---- | ---- | ---- | NC |